BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1703 related articles for article (PubMed ID: 30408744)

  • 1. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
    Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
    Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
    Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
    Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
    Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
    Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of mutant N-acetyl-α-glucosaminidase in mucopolysaccharidosis type IIIB fibroblasts cultured at low temperature.
    Meijer OLM; Te Brinke H; Ofman R; IJlst L; Wijburg FA; van Vlies N
    Mol Genet Metab; 2017 Sep; 122(1-2):100-106. PubMed ID: 28751108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
    Huang W; Xu M; Li R; Baskfield A; Kouznetsova J; Beers J; Zou J; Liu C; Zheng W
    Stem Cell Res; 2019 May; 37():101427. PubMed ID: 30933722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
    Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
    Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease modeling for Mucopolysaccharidosis type IIIB using patient derived induced pluripotent stem cells.
    Huang W; Cheng YS; Yang S; Swaroop M; Xu M; Huang W; Zheng W
    Exp Cell Res; 2021 Oct; 407(1):112785. PubMed ID: 34411609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Construction and Identification of Induced Pluripotent Stem Cells Derived from Acute Myelogenous Leukemia Cells.
    Zhu LF; Chen QR; Chen SZ; Wang LY; Luo XF; Ren JH; Yuan XH; Wu XQ; Zeng YL; Xiao M; Chen YQ; Chen YY; Lin MH; Wu ZJ; Chen ZZ; Hu JD; Yang T
    Cell Physiol Biochem; 2017; 41(4):1661-1674. PubMed ID: 28359056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells.
    Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q
    Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936.
    Toombs J; Panther L; Ornelas L; Liu C; Gomez E; Martín-Ibáñez R; Cox SR; Ritchie SJ; Harris SE; Taylor A; Redmond P; Russ TC; Murphy L; Cooper JD; Burr K; Selvaraj BT; Browne C; Svendsen CN; Cowley SA; Deary IJ; Chandran S; Spires-Jones TL; Sareen D
    Stem Cell Res; 2020 Jul; 46():101851. PubMed ID: 32450543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Screen Fails to Identify Compounds That Enhance Residual Enzyme Activity of Mutant N-Acetyl-α-Glucosaminidase in Mucopolysaccharidosis Type IIIB.
    Meijer OLM; van den Biggelaar P; Ofman R; Wijburg FA; van Vlies N
    JIMD Rep; 2018; 39():97-106. PubMed ID: 28836185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
    Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
    Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.